Source: Annual Congress 2003 - Epidemiological aspects of COPD
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
S. A. Jansson, A. Ericsson, A. Lindberg, S. Borg, A. C. Jonsson, E. Rönmark, F. Andersson, B. Lundbäck (Luleå, Umeå, Lund, Stockholm, Sweden). The main disease-related cost drivers in COPD: impaired lung function and exacerbations. Eur Respir J 2003; 22: Suppl. 45, 1463

Member's Comments

No comment yet.

Related content which might interest you: Irisin is associated with severe exacerbations of COPD independently of lung function, comorbidities and exercise capacity Source: International Congress 2015 – Notable abstracts in COPD: variety Year: 2015 Predictors of lung function deterioration in COPD Source: International Congress 2016 – Phenotyping and monitoring airway diseases Year: 2016 Lung function impairment, COPD hospitalisations and subsequent mortality Source: Annual Congress 2009 - Exacerbations and characteristics of COPD Year: 2009 COPD in the time of COVID-19: an analysis of acute exacerbations and reported behavioural changes in patients with COPD Source: ERJ Open Res, 7 (1) 00718-2020; 10.1183/23120541.00718-2020 Year: 2021 Impact of age-related comorbidities on the risk of COPD exacerbations in subjects with severe airflow limitation: A pan-European study Source: Annual Congress 2013 –COPD mechanisms Year: 2013 The predictors for COPD exacerbations using remote patient monitoring Source: International Congress 2015 – Clinical assessment in asthma and COPD Year: 2015 FEV1 decline in patients with chronic obstructive pulmonary disease: Which treatment option is better for slowing of decline? Source: International Congress 2015 – COPD: exacerbations, gas exchange and associated dysfunction Year: 2015 Static hyperinflation and respiratory disability were associated with frequent-exacerbation phenotype in patients with severe COPD Source: International Congress 2016 – Exploring mechanisms in health and disease Year: 2016 The relationship of exacerbations and lung function decline to radiologic characteristics in COPD Source: Eur Respir J 2005; 26: Suppl. 49, 512s Year: 2005 COPD exacerbation: Influence of severity and type of systemic inflammation on the hospitalizations rate Source: International Congress 2015 – COPD: chronic disease and comorbidities Year: 2015 Difficulty in management of COPD exacerbation: Is this chronic exacerbation or difficult COPD: “A specific phenotype?” Source: Annual Congress 2013 –COPD biomarkers Year: 2013 The impact of comorbidities on the short-term serious health outcomes in hospitalized COPD patients due to exacerbation Source: Annual Congress 2013 –COPD treatment and others Year: 2013 Agreement of severity stages and exacerbations building the new COPD risk groups Source: Annual Congress 2013 –Respiratory and cardiovascular abnormalities in COPD: the role of exercise, nutritional status and inflammation Year: 2013 A global survey conducted to determine frequency of exacerbations in COPD patients Source: Annual Congress 2013 –COPD treatment Year: 2013 COPD exacerbations: impact and prevention Source: Breathe 2013; 9: 434-440 Year: 2013 Alternative ways of expressing FEV1 and mortality in elderly people with and without COPD Source: Eur Respir J 2013; 41: 800-805 Year: 2013 COPD: Influence of patients’ nutritive status on the exacerbations rate Source: International Congress 2016 – COPD diagnosis and management Year: 2016 QVA149 improves lung function and reduces exacerbations compared to tiotropium in patients with severe-to-very severe COPD: The SPARK study Source: Annual Congress 2013 –Asthma and COPD management: novel clinical findings Year: 2013 Severe exacerbations predict excess lung function decline in asthma Source: Eur Respir J 2007; 30: 452-456 Year: 2007 Sit-to-stand ability in patients hospitalised for acute exacerbation of COPD: Clinical characteristics and short-term outcomes Source: International Congress 2015 – New insights into exercise and muscle performance Year: 2015